Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis - Yes.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Oral BG-12 in multiple sclerosis.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Large-scale neuronal network dysfunction in multiple sclerosis?: Evidence from resting-state fMRI.
The nervous system's potential role in multiple sclerosis associated bone loss.
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Personality characteristics in MS patients: The role of avoidant personality.
Multiple sclerosis and oral health--an update.
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Natalizumab-related anaphylactoid reactions in MS patients are associated with HLA class II alleles.
[Biomarkers in neuromyelitis optica].
CCSVI is associated with multiple sclerosis.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton.
Multiple sclerosis and the spinal cord.
Home-Based Balance Training Using the Wii Balance Board: A Randomized, Crossover Pilot Study in Multiple Sclerosis.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
Opexa Amends Agreement with Merck Serono and Receives Additional $3 Million Payment to Support Ongoing Development of Tcelna® for Multiple Sclerosis
Excitotoxic mechanisms of ischemic injury in myelinated white matter.

Pages